Core Points - The company has approved the 2025 semi-annual report and its summary during the board meeting held on August 27, 2025 [17][18][66] - The company will not distribute cash dividends or bonus shares, nor will it increase capital from reserves [3] - The company has decided to cancel the establishment of a healthcare platform company, which will not adversely affect its financial status or operational results [84] Company Overview - The company is named China General Nuclear Power Corporation Technology Development Co., Ltd. [1] - The company has not experienced any changes in its controlling shareholder or actual controller during the reporting period [5][6] Board Meeting Details - All nine directors attended the board meeting, and the meeting was conducted in compliance with relevant laws and regulations [2][10] - The board approved the appointment of the chief accountant as the company's general legal counsel and chief compliance officer [12][79] - The board also approved the cancellation of stock options for 25 departing employees and the second exercise period of stock options that did not meet performance conditions [14][71] Financial Audit - The board has agreed to renew the appointment of Lixin Certified Public Accountants as the financial and internal control audit institution for 2025, with a total audit fee not exceeding RMB 2.5 million [27][63][66] Shareholder Meeting - The company will hold its third extraordinary general meeting of shareholders on September 15, 2025, to discuss various proposals approved by the board [33][40]
中广核核技术发展股份有限公司2025年半年度报告摘要